Citation
Yu, Helen (2019) Subunit Selective Degradation of WIZ, a Lenalidomide- and Pomalidomide-Dependent Substrate of E3 Ubiquitin Ligase CRL4CRBN. Dissertation (Ph.D.), California Institute of Technology. doi:10.7907/Z7PK-NH81. https://resolver.caltech.edu/CaltechTHESIS:04232019-210733826
Abstract
This dissertation is focused on identifying novel targets of immunomodulatory(IMiD) drugs. IMiDs are a class of drugs that are used to treat multiple myeloma.The first chapter is an introduction to the clinical use of IMiDs, as well as the proteincereblon (CRBN), the primary target of IMiDs. The second chapter describes worktowards the identification of a novel IMiD target, WIZ, that is regulated by CRBNin an IMiD dependent manner. Mass spectrometry was performed to identify novelbinding partners, and IMiD dependent regulation by CRBN was validated usingchemical and genetic methods. Understanding how these drugs work will informthe production of more potent and more selective drugs.
Item Type: | Thesis (Dissertation (Ph.D.)) | ||||
---|---|---|---|---|---|
Subject Keywords: | IMiD, PROTAC, Ubiquitin, Proteasome | ||||
Degree Grantor: | California Institute of Technology | ||||
Division: | Chemistry and Chemical Engineering | ||||
Major Option: | Chemistry | ||||
Thesis Availability: | Public (worldwide access) | ||||
Research Advisor(s): |
| ||||
Thesis Committee: |
| ||||
Defense Date: | 25 August 2018 | ||||
Record Number: | CaltechTHESIS:04232019-210733826 | ||||
Persistent URL: | https://resolver.caltech.edu/CaltechTHESIS:04232019-210733826 | ||||
DOI: | 10.7907/Z7PK-NH81 | ||||
ORCID: |
| ||||
Default Usage Policy: | No commercial reproduction, distribution, display or performance rights in this work are provided. | ||||
ID Code: | 11485 | ||||
Collection: | CaltechTHESIS | ||||
Deposited By: | Helen Yu | ||||
Deposited On: | 15 May 2019 16:09 | ||||
Last Modified: | 04 Oct 2019 00:25 |
Thesis Files
|
PDF
- Final Version
See Usage Policy. 8MB |
Repository Staff Only: item control page